Alzheimer’s Drugs: Little Benefit & Research Bias Exposed
For decades, the fight against Alzheimer’s disease has been characterized by a recurring cycle of immense financial investment and crushing disappointment. While the headlines often promise a “breakthrough,” the reality is a sobering realization: tens of billions of dollars have been poured into a pharmaceutical strategy that may have been fundamentally flawed from the start. … Read more